Quest to divest HemoCue diagnostic biz for about $300 million

02/25/2013 | RTT News

Radiometer Medical has agreed to acquire Quest Diagnostics' HemoCue business for about $300 million, plus cash balance adjustments, in a deal set to be finalized next month. HemoCue focuses on developing and marketing point-of-care diagnostics, including those used in glucose and hemoglobin testing.

View Full Article in:

RTT News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Chief Executive Officer
UCare Minnesota
Minneapolis, MN